Pain prevalence in patients with chronic kidney disease

Clinical Nephrology

Volumn 73, Issue 4, 2010, Pages 294-299

  Pham, P C T ^a   Dewar, K ^a   Hashmi, S ^a   Toscano, E ^a   Pham, P M T ^b   Pham, P A T ^c   Pham, P T T ^d  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Mercy General Hospital   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic kidney disease; Pain

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ETHNICITY; FEMALE; GASTROINTESTINAL PAIN; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; PAIN; PATIENT CARE; PERIPHERAL NERVOUS SYSTEM; PREVALENCE; SOCIAL PSYCHOLOGY; UROGENITAL SYSTEM;

ACETAMINOPHEN; ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH SURVEYS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PAIN; PREVALENCE; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; TIME FACTORS;

EID: 77950824612     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs.NEngl J Med. 1984; 310: 563-572.
2. Curhan GC, Knight EL, Rosner B et al. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med. 2004; 164: 1519-1524. (Pubitemid 38970471)
3. Hudson M, Rahme E, Richard H, Pilote L. Risk of congestive heart failure with nonsteroidal anti-inflammatory drugs and selective cyclooxygenase 2 inhibitors: a class effect? Arthritis Rheum. 2007; 57: 516-523. (Pubitemid 46682542)
4. Kurella M, Bennett WM, Chertow GM. Analgesia in patients with ESRD. a review of available evidence. Am J Kidney Dis. 2003; 42: 217-228. (Pubitemid 36944427)
5. Murtagh FEM, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007; 14: 82-99. (Pubitemid 46014531)
6. Pham PC, Toscano E, Pham PM et al. Pain management in patients with chronic kidney disease. Nephrol Dialysis Transpl Plus. 2009; 2: 111-118.
7. Sowers JR, White WB, Pitt B, et al. Celecoxib, rofecoxib efficacy and safety in comorbidities evaluation trial (CRESCENT) Investigators. The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch Intern Med. 2005; 165: 161-168.
8. United States Renal Data System. 2008 Annual Data. www.USRDS.org. Bethesda, MD, USA; 2008.
9. Whelton A, Hamilton CW. Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol. 1991; 31: 588-598.